Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Impact of Estradiol on Endothelial Function in Peri-Menopausal Women 02/05/2020 INTERVENTIONAL not-comparable 2,439.75 0 DOvEEgene Fleur: New Uterine Sampling Tool 02/06/2020 OBSERVATIONAL not-comparable 2,438.75 0 NeoRad Breast Cancer Study 02/07/2020 INTERVENTIONAL not-comparable 2,437.75 0 AFT: Introduction of a Full Breast Reconstructive Method 02/10/2020 OBSERVATIONAL not-comparable 2,434.75 0 Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer 02/10/2020 INTERVENTIONAL not-comparable 2,434.75 0 Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC 02/12/2020 INTERVENTIONAL not-comparable 2,432.75 0 Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer 02/12/2020 INTERVENTIONAL not-comparable 2,432.75 0 Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women 02/13/2020 INTERVENTIONAL not-comparable 2,431.75 0 Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer 02/13/2020 INTERVENTIONAL not-comparable 2,431.75 0 Gestational Diabetes 02/17/2020 OBSERVATIONAL not-comparable 2,427.75 0 Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer 02/17/2020 INTERVENTIONAL not-comparable 2,427.75 0 Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening 02/18/2020 INTERVENTIONAL not-comparable 2,426.75 0 FemBloc® Permanent Contraception - Confirmation Feasibility Trial 02/18/2020 INTERVENTIONAL not-comparable 2,426.75 0 Physician Optimised Post-partum Hypertension Treatment Trial 02/18/2020 INTERVENTIONAL not-comparable 2,426.75 0 Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer 02/18/2020 INTERVENTIONAL not-comparable 2,426.75 0 Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus 02/19/2020 INTERVENTIONAL not-comparable 2,425.75 0 Ovarian Function Following Intraovarian Injection of PRP 02/20/2020 INTERVENTIONAL not-comparable 2,424.75 0 Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy 02/20/2020 INTERVENTIONAL not-comparable 2,424.75 0 Early Antenatal Support for Iron Deficiency Anemia 02/20/2020 INTERVENTIONAL not-comparable 2,424.75 0 Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity 02/24/2020 OBSERVATIONAL not-comparable 2,420.75 0 Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer 02/24/2020 INTERVENTIONAL not-comparable 2,420.75 0 PROADAPT-ovary/EWOC-2 02/26/2020 INTERVENTIONAL not-comparable 2,418.75 0 SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension 02/26/2020 OBSERVATIONAL not-comparable 2,418.75 0 A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer 02/27/2020 INTERVENTIONAL not-comparable 2,417.75 0 Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region 02/28/2020 OBSERVATIONAL not-comparable 2,416.75 0 Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer 03/02/2020 INTERVENTIONAL not-comparable 2,413.75 0 Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease 03/02/2020 OBSERVATIONAL not-comparable 2,413.75 0 Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC 03/03/2020 INTERVENTIONAL not-comparable 2,412.75 0 Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients 03/03/2020 INTERVENTIONAL not-comparable 2,412.75 0 Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) 03/03/2020 INTERVENTIONAL not-comparable 2,412.75 0 TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention 03/04/2020 INTERVENTIONAL not-comparable 2,411.75 0 Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) 03/05/2020 INTERVENTIONAL not-comparable 2,410.75 0 Brain Health in Breast Cancer Survivors 03/05/2020 OBSERVATIONAL not-comparable 2,410.75 0 Preeclampsia Postpartum Antihypertensive Treatment 03/06/2020 INTERVENTIONAL not-comparable 2,409.75 0 A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer 03/06/2020 INTERVENTIONAL not-comparable 2,409.75 0 Community Translation of the Expecting Study 03/06/2020 INTERVENTIONAL not-comparable 2,409.75 0 Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs 03/10/2020 INTERVENTIONAL not-comparable 2,405.75 0 The Role of Oxytocin in the Second Stage of Labor 03/11/2020 INTERVENTIONAL not-comparable 2,404.75 0 No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography 03/11/2020 INTERVENTIONAL not-comparable 2,404.75 0 TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA 03/11/2020 INTERVENTIONAL not-comparable 2,404.75 0 Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A 03/12/2020 INTERVENTIONAL not-comparable 2,403.75 0 Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections 03/12/2020 OBSERVATIONAL not-comparable 2,403.75 0 Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer 03/16/2020 OBSERVATIONAL not-comparable 2,399.75 0 Stroboscopic Vision Training in Softball 03/16/2020 INTERVENTIONAL not-comparable 2,399.75 0 Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy 03/17/2020 INTERVENTIONAL not-comparable 2,398.75 0 Hormone Replacement Trial Against ALzheimers' Disease 03/18/2020 INTERVENTIONAL not-comparable 2,397.75 0 Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients 03/25/2020 INTERVENTIONAL not-comparable 2,390.75 0 Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes 03/27/2020 INTERVENTIONAL not-comparable 2,388.75 0 MRI Screening of Placenta Adhesion Abnormalities 03/31/2020 INTERVENTIONAL not-comparable 2,384.75 0 Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI 04/02/2020 INTERVENTIONAL not-comparable 2,382.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology